RKDA · Arcadia Biosciences, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“With cash and cash equivalents of $4.2 million as of June 30, 2026, the Company believes that its existing cash and cash equivalents will not be sufficient to meet its anticipated cash requirements for at least the next 12 months from the issuance date of these financial statements, and thus raises substantial doubt about the Company's ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.”View the 10-Q filed Aug 13, 2026
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
RKDA Latest Reported Short Interest
FINRA reported 88,674 RKDA shares sold short as of the August 14, 2026 settlement date, an increase of 85,179 shares. Days to cover was 1.00 based on FINRA's reported average daily volume.
Official FINRA short-interest data · share counts are restated for subsequent stock splits
RKDA Short Interest Forecast
Equibles' model estimates 38,329 shares sold short for the August 31, 2026 settlement, -56.8% versus the latest reported position, with a likely range of 7,230 to 89,223 shares. This model prediction uses FINRA data through August 31, 2026; FINRA's official release is expected September 10, 2026.
Expected Aug 31 short interest
as of Aug 31 High confidence 93% chance it fallsPeer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-08-14). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-09-15
Scheduled
FINRA publishes Sep 24
|
— | — | — | — |
|
2026-08-31
Scheduled
FINRA publishes Sep 10
|
— | — | — | — |
| 2026-08-14 | 88,674 | 3,495 | +85,179 | 1.00 |
| 2026-07-31 | 3,495 | 9,653 | -6,158 | 1.00 |
| 2026-07-15 | 9,653 | 23,325 | -13,672 | 1.00 |
| 2026-06-30 | 23,325 | 273,134 | -249,809 | 1.00 |
| 2026-06-15 | 273,134 | 411,143 | -138,009 | 1.00 |
| 2026-05-29 | 411,143 | 9,082 | +402,061 | 1.00 |
| 2026-05-15 | 9,082 | 6,339 | +2,743 | 1.00 |
| 2026-04-30 | 6,339 | 1,595 | +4,744 | 1.00 |
| 2026-04-15 | 1,595 | 927 | +668 | 1.00 |
| 2026-03-31 | 927 | 23,692 | -22,765 | 1.00 |
| 2026-03-13 | 23,692 | 16,307 | +7,385 | 1.00 |
| 2026-02-27 | 16,307 | 15,855 | +452 | 1.05 |
| 2026-02-13 | 15,855 | 10,905 | +4,950 | 1.12 |
| 2026-01-30 | 10,905 | 9,188 | +1,717 | 1.00 |
| 2026-01-15 | 9,188 | 21,517 | -12,329 | 1.00 |
| 2025-12-31 | 21,517 | 41,927 | -20,410 | 1.00 |
| 2025-12-15 | 41,927 | 51,761 | -9,834 | 3.73 |
| 2025-11-28 | 51,761 | 94,939 | -43,178 | 3.82 |
| 2025-11-14 | 94,939 | 130,291 | -35,352 | 3.43 |
| 2025-10-31 | 130,291 | 256,487 | -126,196 | 1.12 |
| 2025-10-15 | 256,487 | 13,018 | +243,469 | 1.00 |
| 2025-09-30 | 13,018 | 15,233 | -2,215 | 2.45 |
| 2025-09-15 | 15,233 | 10,741 | +4,492 | 1.00 |
Full FINRA short interest reporting calendar